本月看到同行评审遭到审查,并在批量审查后生物医学中心对一系列由机构提供虚假评论员的论文的调查。此外,在Twitter和其他网站上还讨论了为快速同行评议付费评论员的道德问题。此外,同行评议是英国政府特别激烈辩论的话题Royal Society在...的时候350th anniversary of its, and indeed any, scholarly publishing。
生物医学中心's handling of their retractions is to be hugely commended, for the swift way in which it was investigated, their collaboration with COPE and other publishers, and their commitment to follow up. Clearly, the issue of agencies fabricating peer review on a large scale is not one that can be resolved in the long term by one publisher, and the responses of institutions will be critical here.
本期文章指出了COPE单独或与其他人共同制定指南的几个领域(例如bob官方app同行评审员的道德bob官方app准则那编辑之间的合作and期刊和机构之间的合作)说明了现代出版伦理的复杂性。特别是,即使一个问题可能在期刊层面曝光,它实际上总是有它的根源在其他地方,期刊和编辑很少能独自负责解决。出版商、机构、作者、编辑和评论员:我们都在一起。